Characteristics of patients with pancreatic cystic lesions
Patient | Sex | Age (y) | No of cysts | Size (mm) | Mutant ras gene |
---|---|---|---|---|---|
1 | M | 58 | 2 | 16 | (3+) |
2 | F | 71 | 3 | 17 | (2+) |
3 | F | 80 | 1 | 15 | (2+) |
4 | F | 62 | 4 | 20 | (2+) |
5 | F | 63 | 2 | 17 | (2+) |
6 | M | 69 | 5 | 25 | (2+) |
7 | F | 73 | 1 | 18 | (1+) |
8 | M | 61 | 2 | 10 | (1+) |
9 | M | 59 | 2 | 10 | (1+) |
10 | M | 53 | 1 | 15 | (+−) |
11 | M | 73 | 2 | 30 | (−) |
12 | F | 62 | >10 | 3 | (−) |
13 | M | 52 | 1 | 40 | (−) |
14 | M | 61 | 2 | 27 | (−) |
Semiquantitative analysis of the mutant gene was scored as (3+), (2+), (1+), (+−), (−) according to the percentage of mutantras gene; (3+), (2+), (1+), (+−), and (−) represented more than 20%, 2–20%, 0.2–2%, less than 0.2%, and 0% (not detected) of the mutant respectively.